Regulatory11 May 2026, 06:41 pm
DCX Systems: Monitoring Agency Report for March 2026
AI Summary
DCX Systems Ltd has released the Monitoring Agency Report by CARE Ratings Limited for the quarter ended March 31, 2026, concerning the utilization of IPO and QIP proceeds. The report indicates that there were deviations from the objects stated in the offer document, requiring shareholder approval, specifically regarding investment in Renal Advanced System Private Limited (RASPL).
Key Highlights
- CARE Ratings Limited issued the Monitoring Agency Report.
- The report covers the utilization of IPO and QIP proceeds.
- Deviations from the original offer document objects were noted.
- Shareholder approval was obtained for material deviations.
- Investment purpose in RASPL was revised to loan repayment.